The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.025
Bid: 0.024
Ask: 0.027
Change: 0.0005 (2.00%)
Spread: 0.003 (12.50%)
Open: 0.026
High: 0.03
Low: 0.025
Prev. Close: 0.025
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction of a Person Closely Associated

27 Mar 2024 07:00

RNS Number : 4209I
Supply@ME Capital PLC
27 March 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

27 March 2024

 

 

Supply@ME Capital plc

(The "Company" or "SYME")

Repayment of TAG Unsecured Working Capital Loan, issue of equity and total voting rights

Notification of Transaction of a Person Closely Associated

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, provides the following funding update with respect to the unsecured working capital loan it entered into with the AvantGarde Group S.p.A. (an entity ultimately beneficially wholly-owned and controlled by Alessandro Zamboni, Chief Executive Officer of the Company) ("TAG").

On 28 April 2023 the Company announced that it had entered into an English law governed fixed term unsecured working capital loan agreement with the TAG (the "TAG Unsecured Working Capital Loan Agreement"). Subsequently on 30 June 2023, the Company announced that in connection with the disposal of the majority 81% stake of TradeFlow Capital Management Pte. Limited, the obligations under the TAG Unsecured Working Capital Loan Agreement had been amended and the full amount available to be drawn down by the Company from TAG was £800,000, for which the draw down was notified to TAG by the Company on 30 June 2023.

Furthermore, on 29 February 2024, the Company announced that the full £800,000 drawn down had been received by the Company in cash and as a result no further amounts were outstanding under the TAG Unsecured Working Capital Loan Agreement. The due date for repayment by the Company of the £800,0000 was to be 1 February 2028. Any sums drawn under the TAG Unsecured Working Capital Loan Agreement have been attracting a non-compounding interest rate of 10% per annum, and any principal amount (excluding accrued interest) outstanding on 1 February 2028 shall attract a compounding interest rate of 15% per annum thereafter.

On 26 March 2024, the Company and TAG entered into an English law governed deed of amendment, which amended and restated the repayment method set out in the TAG Unsecured Working Capital Loan Agreement (the "Second Deed of Amendment to the TAG Working Capital Loan Agreement"). The Second Deed of Amendment to the TAG Working Capital Loan Agreement stipulated that:

a) the £800,000 amount drawn down under the TAG Unsecured Working Capital Loan Agreement is to be repaid through the issue of 1,500,000,000 new ordinary shares of nominal value £0.00002 each in the capital of the Company ("Ordinary Shares") to TAG, resulting in a fixed subscription price per share of 0.053p; and

b) the interest payable by the Company under the TAG Unsecured Working Capital Loan Agreement will be offset against the interest receivable by the Company from TAG under the other contractual funding arrangements currently in place with TAG.

The entry by the Company and TAG into the Second Deed of Amendment to the TAG Working Capital Loan Agreement constitutes a material related party transaction for the purposes of DTR 7.3 and was, accordingly, voted upon by the independent Directors (excluding Alessandro Zamboni, who, constituted a "related party" (as such term is defined in IFRS)), and the independent Directors consider the material related party transaction in respect of the Second Deed of Amendment to the TAG Unsecured Working Capital Loan Agreement to be fair and reasonable from the perspective of the Company and its Shareholders who are not a related party.

The repayment of the £800,000, due in accordance with the TAG Unsecured Working Capital Loan Agreement, through the issue of 1,500,000,000 new Ordinary Shares in the Company to TAG will allow the Company to preserve its cash position in the future, save the Company future interest costs and improve the Company's net asset position. TAG have also provided representations to the Company that the issue of the 1,500,000,000 new Ordinary Shares in the Company will enable TAG to continue to perform under the various contractual funding arrangements that it has entered into with the Company, as TAG expects these new Ordinary Shares to be included into a potential collateral package to secure additional funding for TAG from traditional financial services providers including, inter alia, private banking operators.

Prior to the entry into the Second Deed of Amendment to the TAG Working Capital Loan Agreement, the Company sought the approvals that were required from Venus Capital S.A. under the subscription agreement dated 28 April 2023 (the "Subscription Agreement") to be able to issue and allot the 1,500,000,000 new Ordinary Shares to TAG.

The Company has made applications to the Financial Conduct Authority (the "FCA") and London Stock Exchange plc (the "LSE") to have the 1,500,000,000 new Ordinary Shares admitted to listing on the standard segment of the Official List of the FCA and to trading on the main market for listed securities of the LSE, respectively, with admission expected to occur on or around 28 March 2024 ("Admission").

Following Admission, the Company's issued share capital will comprise 62,732,142,145 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehoused goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAFDKALNLEAA
Date   Source Headline
5th Apr 20247:00 amRNSBusiness update
4th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransfer of Warrants
27th Mar 20247:00 amRNSTransaction of a Person Closely Associated
22nd Mar 20247:00 amRNSPDMR/PCA shareholding: stock loans update
29th Feb 20247:00 amRNSBusiness, trading and funding update
19th Feb 20247:00 amRNSExercise of warrants, issue of equity and TVR
26th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20247:00 amRNSExercise of warrants, issue of equity and TVR
3rd Jan 20247:00 amRNSWhite-Label IM Agreement - funding secured
5th Dec 20238:40 amRNSFunding and Business update
23rd Nov 20237:00 amRNSTransfer of Warrants
6th Nov 20237:00 amRNSExercise of Warrants, issue of equity and TVR
1st Nov 20238:58 amRNSTotal Voting Rights
10th Oct 20237:00 amRNSExercise of Warrants, issue of equity and TVR
29th Sep 20237:00 amRNSHalf-year Report
25th Sep 20237:00 amRNSExercise of Warrants, issue of equity and TVR
12th Sep 20237:00 amRNSExercise of Open Offer Warrants
1st Sep 20237:00 amRNSTotal Voting Rights
17th Aug 20237:00 amRNSExercise of options, issue of equity and TVR
4th Aug 202312:34 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSTotal Voting Rights
7th Jul 20237:00 amRNSDirector/PDMR Shareholding
5th Jul 20237:00 amRNSExercise of Warrants, issue of equity and TVR
3rd Jul 20237:00 amRNSExecution of first UK IM using traditional funding
30th Jun 20235:36 pmRNSHolding(s) in Company
30th Jun 202312:54 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSTransaction of a Person Closely Associated
23rd Jun 20235:37 pmRNSResult of General Meeting
23rd Jun 20235:36 pmRNSResult of AGM
15th Jun 202311:00 amRNSReplacement Total Voting Rights
15th Jun 20238:00 amRNSNew Italian PNP regulation comes into effect
13th Jun 20237:00 amRNSExercise of Warrants, issue of equity and TVR
9th Jun 20237:00 amRNSFirst UK IM transaction from traditional funding
5th Jun 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
2nd Jun 202312:51 pmRNSHolding in Company
31st May 20233:56 pmRNSNotice of GM of Open Offer Warrantholders
31st May 20233:55 pmRNSNotice of Annual General Meeting
26th May 20237:00 amRNSAdmission of Shares and Total Voting Rights
23rd May 20237:00 amRNSExercise of Warrants, Issue of Equity and TVR
22nd May 20237:00 amRNSGrant of Awards under the Supply@ME LTIP
19th May 20231:40 pmRNSHolding(s) in Company
16th May 20237:00 amRNSInvestor Presentation via Investor Meet Company
9th May 20233:03 pmRNSHolding(s) in Company
5th May 20237:00 amRNSExecution of first IM from traditional funding
4th May 202312:40 pmRNSAdmission and Exercise of Open Offer Warrants
2nd May 202312:00 pmRNSSYME moves to SETS trading platform
28th Apr 20232:51 pmRNS2022 Annual Report and Accounts and Financing
26th Apr 20237:00 amRNSCommitment for first IM from traditional funding
13th Apr 202310:59 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.